KRAS, KRAS proto-oncogene, GTPase, 3845

N. diseases: 1213; N. variants: 54
Disease: Thyroid Neoplasm ×
Source: ALL
Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs17851045
rs17851045
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
CUI: C0040136
Disease:
Thyroid Neoplasm 		A 0.700 GeneticVariation CLINVAR Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 26619011 2016
dbSNP: rs1057519725
rs1057519725
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
CUI: C0040136
Disease:
Thyroid Neoplasm 		A 0.700 CausalMutation CLINVAR Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. 23406027 2013
dbSNP: rs112445441
rs112445441
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
CUI: C0040136
Disease:
Thyroid Neoplasm 		T 0.700 CausalMutation CLINVAR Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. 23406027 2013
dbSNP: rs121913238
rs121913238
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
CUI: C0040136
Disease:
Thyroid Neoplasm 		T 0.700 CausalMutation CLINVAR Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. 23406027 2013
dbSNP: rs121913240
rs121913240
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
CUI: C0040136
Disease:
Thyroid Neoplasm 		A 0.700 CausalMutation CLINVAR Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. 23406027 2013
dbSNP: rs121913240
rs121913240
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
CUI: C0040136
Disease:
Thyroid Neoplasm 		G 0.700 CausalMutation CLINVAR Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. 23406027 2013
dbSNP: rs121913240
rs121913240
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
CUI: C0040136
Disease:
Thyroid Neoplasm 		C 0.700 CausalMutation CLINVAR Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. 23406027 2013
dbSNP: rs121913529
rs121913529
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
CUI: C0040136
Disease:
Thyroid Neoplasm 		A 0.700 CausalMutation CLINVAR Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. 23406027 2013
dbSNP: rs121913529
rs121913529
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
CUI: C0040136
Disease:
Thyroid Neoplasm 		T 0.700 CausalMutation CLINVAR Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. 23406027 2013
dbSNP: rs121913530
rs121913530
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
CUI: C0040136
Disease:
Thyroid Neoplasm 		T 0.700 CausalMutation CLINVAR Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. 23406027 2013
dbSNP: rs121913530
rs121913530
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
CUI: C0040136
Disease:
Thyroid Neoplasm 		A 0.700 CausalMutation CLINVAR Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. 23406027 2013
dbSNP: rs121913530
rs121913530
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
CUI: C0040136
Disease:
Thyroid Neoplasm 		G 0.700 CausalMutation CLINVAR Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. 23406027 2013
dbSNP: rs121913535
rs121913535
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
CUI: C0040136
Disease:
Thyroid Neoplasm 		G 0.700 CausalMutation CLINVAR Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. 23406027 2013
dbSNP: rs121913535
rs121913535
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
CUI: C0040136
Disease:
Thyroid Neoplasm 		T 0.700 CausalMutation CLINVAR Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. 23406027 2013
dbSNP: rs1057519725
rs1057519725
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
CUI: C0040136
Disease:
Thyroid Neoplasm 		A 0.700 CausalMutation CLINVAR Phase II trial of sorafenib in metastatic thyroid cancer. 19255327 2009
dbSNP: rs1057519725
rs1057519725
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
CUI: C0040136
Disease:
Thyroid Neoplasm 		A 0.700 CausalMutation CLINVAR Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma. 19773371 2009
dbSNP: rs112445441
rs112445441
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
CUI: C0040136
Disease:
Thyroid Neoplasm 		T 0.700 CausalMutation CLINVAR Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma. 19773371 2009
dbSNP: rs112445441
rs112445441
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
CUI: C0040136
Disease:
Thyroid Neoplasm 		T 0.700 CausalMutation CLINVAR Phase II trial of sorafenib in metastatic thyroid cancer. 19255327 2009
dbSNP: rs121913238
rs121913238
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
CUI: C0040136
Disease:
Thyroid Neoplasm 		T 0.700 CausalMutation CLINVAR Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma. 19773371 2009
dbSNP: rs121913238
rs121913238
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
CUI: C0040136
Disease:
Thyroid Neoplasm 		T 0.700 CausalMutation CLINVAR Phase II trial of sorafenib in metastatic thyroid cancer. 19255327 2009
dbSNP: rs121913240
rs121913240
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
CUI: C0040136
Disease:
Thyroid Neoplasm 		G 0.700 CausalMutation CLINVAR Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma. 19773371 2009
dbSNP: rs121913240
rs121913240
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
CUI: C0040136
Disease:
Thyroid Neoplasm 		A 0.700 CausalMutation CLINVAR Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma. 19773371 2009
dbSNP: rs121913240
rs121913240
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
CUI: C0040136
Disease:
Thyroid Neoplasm 		C 0.700 CausalMutation CLINVAR Phase II trial of sorafenib in metastatic thyroid cancer. 19255327 2009
dbSNP: rs121913240
rs121913240
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
CUI: C0040136
Disease:
Thyroid Neoplasm 		C 0.700 CausalMutation CLINVAR Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma. 19773371 2009
dbSNP: rs121913240
rs121913240
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
CUI: C0040136
Disease:
Thyroid Neoplasm 		G 0.700 CausalMutation CLINVAR Phase II trial of sorafenib in metastatic thyroid cancer. 19255327 2009